← Leaderboards
Aloke K Dutta
Wayne State University
$7,837,062
Attributed
$7,837,062
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $835.4K · FY2005–15$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
Funding mix
By agency
NIH$7,837,062 · 3
By mechanism
R01$7,837,062 · 3
Top collaborators
No co-investigators on record.
Most similar at Wayne State University
Same institution · by research overlap
- Robert R Freedman$15,174,313
- Stephanie Brock$3,905,946
Others in their field
Top investigators on “Dopamine”
- Pedro A. Jose · George Washington University$34,248,029
- Jonathan A Javitch · Columbia University Health Sciences$28,566,988
- Michael A Nader · Emory University$26,344,520
- Dalton James Surmeier · University Of Tennessee Health Sci Ctr$23,527,588
- Michael A Schwarzschild · Massachusetts General Hospital$22,973,787
- David Sulzer · Columbia University Health Sciences$22,837,505
Research focus
DopamineDopamine TransporterLeadResearch StudyDoseBaseAffinityResponseExhibitsIn VitroPropertyRattusIn VivoDesignAnimal ModelStructure-Activity RelationshipBiological AvailabilityAnalogBinding (Molecular Function)AcuteDrug KineticsChronicFollow-UpDopamine Agonists
Grant awards (23)
Novel Neuroprotective Treatment for Parkinson's Disease$453,516
R01 · FY2015 · NS · contact PI
Novel Neuroprotective Treatment for Parkinson's Disease$442,842
R01 · FY2014 · NS · contact PI
Novel Neuroprotective Treatment for Parkinson's Disease$427,734
R01 · FY2013 · NS · contact PI
Novel Triple Uptake Inhibitors for Treatment of Depression$368,510
R01 · FY2013 · MH · contact PI
Novel Neuroprotective Treatment for Parkinson's Disease$451,485
R01 · FY2012 · NS · contact PI
Novel Triple Uptake Inhibitors for Treatment of Depression$383,865
R01 · FY2012 · MH · contact PI
Novel Triple Uptake Inhibitors for Treatment of Depression$386,421
R01 · FY2011 · MH · contact PI
Novel Neuroprotective Treatment for Parkinson's Disease$363,146
R01 · FY2011 · NS · contact PI
Novel Triple Uptake Inhibitors for Treatment of Depression$390,325
R01 · FY2010 · MH · contact PI
Novel Triple Uptake Inhibitors for Treatment of Depression$403,325
R01 · FY2009 · MH · contact PI
Novel Neuroprotective Treatment for Parkinson's Disease$274,383
R01 · FY2009 · NS · contact PI
Novel Neuroprotective Treatment for Parkinson's Disease$357,215
R01 · FY2008 · NS · contact PI
Dopamine Transporter Agents Against Cocaine Dependence$368,490
R01 · FY2007 · DA · contact PI
Novel Neuroprotective Treatment for Parkinson's Disease$357,575
R01 · FY2007 · NS · contact PI
Dopamine Transporter Agents Against Cocaine Dependence$368,442
R01 · FY2006 · DA · contact PI
Novel Neuroprotective Treatment for Parkinson's Disease$266,342
R01 · FY2006 · NS · contact PI
Dopamine Transporter Agents Against Cocaine Dependence$404,618
R01 · FY2005 · DA
Novel Neuroprotective Treatment for Parkinson's Disease$294,217
R01 · FY2005 · NS
DOPAMINE TRANSPORTER AGENTS AGAINST COCAINE DEPENDENCE$273,060
R01 · FY2003 · DA
DOPAMINE TRANSPORTER AGENTS AGAINST COCAINE DEPENDENCE$18,587
R01 · FY2003 · DA
DOPAMINE TRANSPORTER AGENTS AGAINST COCAINE DEPENDENCE$268,739
R01 · FY2002 · DA
DOPAMINE TRANSPORTER AGENTS AGAINST COCAINE DEPENDENCE$260,914
R01 · FY2001 · DA
DOPAMINE TRANSPORTER AGENTS AGAINST COCAINE DEPENDENCE$253,311
R01 · FY2000 · DA